AAAAAA
Results:
1-18
|
Results: 18
Authors:
GOA KL
BARRADELL LB
MCTAVISH D
Citation: Kl. Goa et al., SIMVASTATIN - A REAPPRAISAL OF ITS COST-EFFECTIVENESS IN DYSLIPIDEMIAAND CORONARY HEART-DISEASE, PharmacoEconomics, 11(1), 1997, pp. 89-114
Authors:
JEAL W
BARRADELL LB
MCTAVISH D
Citation: W. Jeal et al., ALENDRONATE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN POSTMENOPAUSAL OSTEOPOROSIS, Drugs, 53(3), 1997, pp. 415-434
Authors:
GOA KL
BARRADELL LB
PLOSKER GL
Citation: Kl. Goa et al., BEZAFIBRATE - AN UPDATE OF ITS PHARMACOLOGY AND USE IN THE MANAGEMENTOF DYSLIPIDEMIA - DRUGS (VOL 52, PG 725, 1996), Drugs, 53(1), 1997, pp. 188-188
Authors:
BARRADELL LB
FITTON A
Citation: Lb. Barradell et A. Fitton, TANDOSPIRONE, CNS DRUGS, 5(2), 1996, pp. 147-153
Authors:
PLOSKER GL
BARRADELL LB
Citation: Gl. Plosker et Lb. Barradell, CYCLOSPORINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND ROLE INTHE MANAGEMENT OF GRAFT-VERSUS-HOST DISEASE, CLINICAL IMMUNOTHERAPEUTICS, 5(1), 1996, pp. 59-90
Authors:
BARRADELL LB
BROGDEN RN
Citation: Lb. Barradell et Rn. Brogden, ORAL NAFTIDROFURYL - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USEIN THE MANAGEMENT OF PERIPHERAL OCCLUSIVE ARTERIAL-DISEASE, Drugs & aging, 8(4), 1996, pp. 299-322
Authors:
GOA KL
BARRADELL LB
PLOSKER GL
Citation: Kl. Goa et al., BEZAFIBRATE - AN UPDATE OF ITS PHARMACOLOGY AND USE IN THE MANAGEMENTOF DYSLIPIDEMIA, Drugs, 52(5), 1996, pp. 725-753
Authors:
SPENCER CM
BARRADELL LB
Citation: Cm. Spencer et Lb. Barradell, GEMFIBROZIL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND PLACE IN THE MANAGEMENT OF DYSLIPIDEMIA, Drugs, 51(6), 1996, pp. 982-1018
Authors:
BALFOUR JA
FITTON A
BARRADELL LB
Citation: Ja. Balfour et al., LORNOXICAM - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF PAINFUL AND INFLAMMATORY CONDITIONS, Drugs, 51(4), 1996, pp. 639-657
Authors:
DUNN HJ
BARRADELL LB
Citation: Hj. Dunn et Lb. Barradell, AZITHROMYCIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND USE AS 3-DAY THERAPY IN RESPIRATORY-TRACT INFECTIONS, Drugs, 51(3), 1996, pp. 483-505
Authors:
BARRADELL LB
Citation: Lb. Barradell, FLUCONAZOLE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN MAJOR SUPERFICIAL AND SYSTEMIC MYCOSESIN IMMUNOCOMPROMISED PATIENTS (VOL 50, PG 658, 1995), Drugs, 51(3), 1996, pp. 505-505
Authors:
BARRADELL LB
GOA KL
Citation: Lb. Barradell et Kl. Goa, ALTEPLASE - A PHARMACOECONOMIC EVALUATION OF ITS USE IN THE MANAGEMENT OF MYOCARDIAL-INFARCTION, PharmacoEconomics, 8(5), 1995, pp. 428-459
Authors:
GOA KL
BARRADELL LB
Citation: Kl. Goa et Lb. Barradell, FLUCONAZOLE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN MAJOR SUPERFICIAL AND SYSTEMIC MYCOSESIN IMMUNOCOMPROMISED PATIENTS, Drugs, 50(4), 1995, pp. 658-690
Authors:
BARRADELL LB
FITTON A
Citation: Lb. Barradell et A. Fitton, ARTESUNATE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY INTHE TREATMENT OF MALARIA, Drugs, 50(4), 1995, pp. 714-741
Authors:
BARRADELL LB
FAULDS D
Citation: Lb. Barradell et D. Faulds, CYPROTERONE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN PROSTATE-CANCER, Drugs & aging, 5(1), 1994, pp. 59-80
Authors:
BARRADELL LB
BRYSON HM
Citation: Lb. Barradell et Hm. Bryson, CEFEPIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE, Drugs, 47(3), 1994, pp. 471-505
Authors:
BARRADELL LB
PLOSKER GL
MCTAVISH D
Citation: Lb. Barradell et al., CLARITHROMYCIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN MYCOBACTERIUM-AVIUM-INTRACELLULARE COMPLEX INFECTION IN PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME, Drugs, 46(2), 1993, pp. 289-312
Authors:
BARRADELL LB
MCTAVISH D
Citation: Lb. Barradell et D. Mctavish, HISTRELIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC ROLE IN CENTRAL PRECOCIOUS PUBERTY, Drugs, 45(4), 1993, pp. 570-588
Risultati:
1-18
|